BRIEF-Sangamo Biosciences comments on 2008 progress, 2009 objectives -
SGMO: To Present At Piper Jaffray Health Care Conference @ 16:30 ET [delayed] -
Sangamo BioSciences to Webcast Update, Conference Presentation -
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee -
Sangamo Biosciences Finishes At 6-Year Low -
Stockwire.com: Sangamo BioSciences, Inc. (Nasdaq: SGMO) just released some important news. -
Sangamo shares sink after nerve drug fails trial -
Sangamo reports top-line data from Phase II diabetic neuropathy trial -
Sangamo Biosciences Eases In Pre-Market After Reporting Diabetic Neuropathy Clinical Trial Results -
UPDATE 1-Sangamo nerve drug fails a mid-stage trial, shares sink -
Sangamo Biosciences Hits New Low During After-Hours -
BRIEF-Sangamo announces results from diabetic neuropathy clinical trial -
Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 -
SGMO: Q3 Earnings Call @ 17:00 ET Today [delayed] -
Sangamo BioSciences Announces Third Quarter Conference Call and Webcast -